Quality control is paramount in biopharmaceutical development to ensure the safety, efficacy, and consistency of therapeutic products. Robust DNA, RNA, and protein quality control measures are essential for mitigating risks, enhancing product quality, ensuring compliance with regulations and delivering safe and effective biopharmaceutical products to patients. Avance Biosciences™ offers state-of-the-art solutions for DNA, RNA, and protein quality control, leveraging advanced platforms such as the NanoDrop 1000 Spectrophotometer, NanoDrop One Spectrophotometer, and Agilent 2100 Bioanalyzer.
NanoDrop 1000 Spectrophotometer:
The NanoDrop 1000 Spectrophotometer is a compact and versatile instrument designed for rapid and accurate quantification of nucleic acids and proteins.
NanoDrop One Spectrophotometer:
The NanoDrop One Spectrophotometer represents the next generation of spectrophotometry technology, offering enhanced performance, versatility, and connectivity for DNA, RNA, and protein analysis.
Agilent 2100 Bioanalyzer:
The Agilent 2100 Bioanalyzer is a high-performance microfluidic electrophoresis system designed for automated analysis of DNA, RNA, and proteins.
Avance Biosciences™ leverages the advanced capabilities of the NanoDrop 1000 Spectrophotometer, NanoDrop One Spectrophotometer, and Agilent 2100 Bioanalyzer to provide comprehensive solutions for DNA, RNA, and protein quality control in biopharmaceutical development. For rapid quantification, advanced optical performance, and multiplex analysis, our platforms are equipped to meet quality control needs with accuracy, efficiency, and reliability. Contact us today to learn more about how we can support your biopharmaceutical development initiatives.